 Multicenter study superficial bladder cancer intravesical bacillus Calmette-Guerin adriamycin Results long-term follow-up cases patients superficial bladder cancers Stages Ta Tis cases intravesical bacillus Calmette-Guerin BCG Tice strain Adriamycin ADR multicenter study thirty-one patients results percentage initial complete remissions BCG ADR additional therapy BCG ADR complete remission percent patients failures patients ADR BCG disease rate complete remission BCG percent recurrence rate patient-months different BCG ADR percentage progressions BCG ADR percent BCG patients Cox regression model covariates drug treatment tumor grade sex significant failures protocol BCG ADR effective course study BCG drug choice residual tumor Stages Tis